Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Percutaneous coronary intervention prior coronary bypass surgery
Introduction
2005 ACC/AHA/SCAI Guidelines for Percutaneous Coronary Intervention (DO NOT EDIT)[1]
2005 ACC/AHA/SCAI Guidelines for Percutaneous Coronary Intervention (DO NOT EDIT)[1]
PCI in patients with Prior Coronary Bypass Surgery (DO NOT EDIT)[1]
| Class I |
| “1. When technically feasible, PCI should be performed in patients with early ischemia (usually within 30 days) after CABG. (Level of Evidence: B)” |
| “2. It is recommended that distal embolic protection devices be used when technically feasible in patients undergoing PCI to saphenous vein grafts. (Level of Evidence: B)” |
| Class III |
| “1. PCI is not recommended in patients with prior CABG for chronic total vein graft occlusions.(Level of Evidence: B)” |
| “2. PCI is not recommended in patients who have multiple target lesions with prior CABG and who have multi-vessel disease failure of multiple SVGs, and impaired LV function unless repeat CABG poses excessive risk due to severe comorbid conditions. (Level of Evidence: B)” |
| Class IIa |
| “1. PCI is reasonable in patients with ischemia that occurs 1 to 3 years after CABG and who have preserved LV function with discrete lesions in graft conduits. (Level of Evidence: B)” |
| “2. PCI is reasonable in patients with disabling angina secondary to new disease in a native coronary circulation after CABG. (If angina is not typical, objective evidence of ischemia should be obtained.) (Level of Evidence: B)” |
| “3. PCI is reasonable in patients with diseased vein grafts more than 3 years after CABG. (Level of Evidence: B)” |
| “4. PCI is reasonable when technically feasible in patients with a patent left internal mammary artery graft who have clinically significant obstructions in other vessels. (Level of Evidence: C)” |
References
References
- ↑ 1.0 1.1 Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB; et al. (2006). “ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention)”. Circulation. 113 (7): e166–286. doi:10.1161/CIRCULATIONAHA.106.173220. PMID 16490830.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]